Key Takeaways UiPath's 4.18X forward P/S ratio undercuts the industry average of 5.85X, signaling potential undervaluation. PATH's RPA platform powers digital shifts in finance, healthcare and logistics with strong recurring revenue. Partnerships with Microsoft and SAP reinforce PATH's enterprise edge and automation-first growth strategy.UiPath Inc. (PATH) is trading at a discount that growth investors shouldn't ignore. With a forward 12-month price-to-sales (P/S) ratio of just 4.18X — well below the indu ...